IPAB postpones hearing on Natco’s CL for Bayer’s Nexavar to Sept 3
Focus shifts to Novartis India's challenge to Section 3 (d), scheduled for tomorrow
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
US FDA clears Claris Lifesciences’ facility after remedial action
Approval allows Claris to re-enter US market
‘It is a critical time to capitalise on the biotech opportunities available within…
James C Greenwood, President and CEO, Biotechnology Industry Organisation (BIO) and a former Congressman from Pennsylvania, US…
CPhI Worldwide 2012 to raise success story of Indian pharma industry
Event to be held in Feria de Madrid, Spain from October 9 to 11, 2012
A clarion call to step up research for AIDS vaccine
India renews its commitment towards collaborative HIV vaccine research: DBT and IAVI set up a new lab devoted to the same
Gleevec, Nexavar cases put India’s IP laws to test
The debate on patents vs patients remains on the boil, with the Bayer/ Nexavar and Novartis/ Gleevec cases keeping the issue live.…
CDSCO to increase headcount of NDAC, MDAC committees
The last date for submitting applications is September 28
ACG Pharmapack’s ‘Alukbiss – alu look film’ wins award for excellence in packaging
Receives INDIASTAR 2012, an award for excellence in packaging
Wockhardt launches generic version of anti-depressant drug Wellbutrin SR
It will manufacture the extended release tablets at its facility in Waluj
FDA approves new treatment for late stage prostate cancer
Xtandi was reviewed under the FDA’s priority review programme